Rua Bioscience Limited logo

Results of 2025 Annual Shareholders' Meeting

AGM28 October 2025RUAHealthcare

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com
 

 

 


FOR PUBLIC RELEASE


NZX Limited

Wellington


29 October 2025



Results of Rua Bioscience Limited’s 2025 Annual Shareholders’ Meeting


At Rua Bioscience’s virtual Annual Shareholder’s Meeting held online at 3:00pm, 28

October 2025, shareholders were asked to vote on four ordinary resoliutions which were

supported by the Board. As required by NZX lisitng rule 6.1, alll voting was conducted by

a poll.


The resolutions passed by shareholders were as follows:


1) Resolution 1 - That the Board be authorised to fix the auditor’s remuneration.


2) Resolution 2- That Teresa Ciprian, who retires and is eligible for re-election, be re-

elected as a Director of Rua.


3) Resolution 3 - That, in accordance with NZX Listing Rule 4.5.1(c), the shareholders

approve and ratify for all purposes, the previous issue of:

a. 16,799,999 fully paid ordinary shares in the Company (the Placement

Shares), issued by way of a private placement under NZX Listing Rule 4.5.1

to selected wholesale investors at an issue price of $0.03 per share, and

allotted between 7 August 2025 and 11 September 2025; and

b. 5,926,673 warrants in the Company (the Warrants), each entitling the

holder to subscribe for one fully paid ordinary share in the Company at an

exercise price of $0.015 per share (payable on exercise), issued under NZX

Listing Rule 4.5.1 to certain wholesale investors in connection with debt

facility arrangements, and allotted between 14 May 2025 and 11

September 2025.


4) Resolution 4 - That the Directors are authorised to issue up to 49,993,744 new

ordinary fully paid shares in the Company (New Shares) on the following terms:

a. The New Shares may be issued to any person subject to the Company

complying with the requirements of the Financial Markets Conduct Act

2013 and the NZX Listing Rules in relation to any such issue.

b. The New Shares may be issued through a single placement of up to

49,993,744 New Shares or via separate placements of up to 49,993,744

New Shares in aggregate.

ASM Results 

 
PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com

c. Each New Share shall be issued at an issue price of not less than $0.03.

d. The New Shares may be issued at any time during the course of the 12-

month period following the passing of this resolution.

e. The New Shares, when issued, shall rank pari passu (equally) with all

existing ordinary shares in the Company.


Detail of the total number of votes cast in person or by a proxy holder are:


Resolution For Against Abstain

Fix Auditor’s remuneration 43,381,911

99.08%

404,064

0.92%

1,041,144

That Teresa Ciprian be re-elected 41,946,224

98.53%

625,953

1.47%

2,254,942

Approve the previous issues 32,652,626

98.17%

608,327

1.83%

11,566,166

Directors be authorised to issue New Shares 38,582,014

95.57%

1,789.982

4.43%

4,455,123



ENDS 


The person who authorised this announcement:


Paul Naske

Chief Executive Officer

paul.naske@ruabio.com

+64 21 445154

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.